Company Registration No. 06327563 (England and Wales)
Mulla Pharma Limited
Filleted accounts
for the year ended 31 October 2023
Mulla Pharma Limited
Filleted accounts
Contents
Mulla Pharma Limited
Company Information
for the year ended 31 October 2023
Company Number
06327563 (England and Wales)
Registered Office
73 Colchester Road
Leicester
LE5 2DJ
Accountants
YP Finance
Hawthorne House
17A Hawthorne Drive
Leicester
Leicestershire
LE5 6DL
Mulla Pharma Limited
Statement of financial position
as at 31 October 2023
Cash at bank and in hand
119,841
98,405
Creditors: amounts falling due within one year
(5,824)
(31,686)
Net current assets
114,017
66,719
Called up share capital
1
1
Profit and loss account
114,017
66,719
Shareholders' funds
114,018
66,720
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 31 July 2024 and were signed on its behalf by
Mr N Patel
Director
Company Registration No. 06327563
Mulla Pharma Limited
Notes to the Accounts
for the year ended 31 October 2023
Mulla Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 06327563. The registered office is 73 Colchester Road, Leicester, LE5 2DJ.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
4
Investments
Other investments
Valuation at 1 November 2022
1
Valuation at 31 October 2023
1
5
Creditors: amounts falling due within one year
2023
2022
Taxes and social security
629
3,979
Other creditors
4,674
27,294
Mulla Pharma Limited
Notes to the Accounts
for the year ended 31 October 2023
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1
1
7
Average number of employees
During the year the average number of employees was 2 (2022: 2).